Raymond James & Associates’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-223,019
| Closed | -$198K | – | 3970 |
|
|
2022
Q4 | $198K | Sell |
223,019
-34,300
| -13% | -$30.4K | ﹤0.01% | 3431 |
|
|
2022
Q3 | $404K | Buy |
257,319
+101,500
| +65% | +$159K | ﹤0.01% | 2978 |
|
|
2022
Q2 | $313K | Sell |
155,819
-11,006
| -7% | -$22.1K | ﹤0.01% | 3189 |
|
|
2022
Q1 | $389K | Sell |
166,825
-12,932
| -7% | -$30.2K | ﹤0.01% | 3211 |
|
|
2021
Q4 | $836K | Buy |
179,757
+28,000
| +18% | +$130K | ﹤0.01% | 2736 |
|
|
2021
Q3 | $1.16M | Buy |
151,757
+39,300
| +35% | +$300K | ﹤0.01% | 2479 |
|
|
2021
Q2 | $1.09M | Buy |
112,457
+26,186
| +30% | +$254K | ﹤0.01% | 2528 |
|
|
2021
Q1 | $713K | Sell |
86,271
-23,364
| -21% | -$193K | ﹤0.01% | 2738 |
|
|
2020
Q4 | $748K | Sell |
109,635
-8,185
| -7% | -$55.8K | ﹤0.01% | 2525 |
|
|
2020
Q3 | $1.31M | Sell |
117,820
-114,009
| -49% | -$1.27M | ﹤0.01% | 2007 |
|
|
2020
Q2 | $1.46M | Buy |
231,829
+220,579
| +1,961% | +$1.39M | ﹤0.01% | 1913 |
|
|
2020
Q1 | $21K | Buy |
+11,250
| New | +$21K | ﹤0.01% | 3341 |
|
|
2016
Q2 | – | Sell |
-16,000
| Closed | -$86K | – | 2967 |
|
|
2016
Q1 | $86K | Buy |
+16,000
| New | +$86K | ﹤0.01% | 2714 |
|